These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 34019585)
1. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH). Urraza-Robledo AI; Giralt M; González-Galarza FF; Villarroya F; Miranda Pérez AA; Ruiz Flores P; Gutiérrez Pérez ME; Domingo P; López-Márquez FC PLoS One; 2021; 16(5):e0252144. PubMed ID: 34019585 [TBL] [Abstract][Full Text] [Related]
2. Serum FGF21 in girls with anorexia nervosa - comparison to normal weight and obese female adolescents. Mikolajczak A; Oswiecimska JM; Swietochowska E; Roczniak W; Ziora KT Neuro Endocrinol Lett; 2017 Jul; 38(3):173-181. PubMed ID: 28759185 [TBL] [Abstract][Full Text] [Related]
3. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Zhang X; Yeung DC; Karpisek M; Stejskal D; Zhou ZG; Liu F; Wong RL; Chow WS; Tso AW; Lam KS; Xu A Diabetes; 2008 May; 57(5):1246-53. PubMed ID: 18252893 [TBL] [Abstract][Full Text] [Related]
4. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation. Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601 [TBL] [Abstract][Full Text] [Related]
5. FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment. Ruiz-Padilla AJ; Ruiz-Noa Y; Del Rocio Ibarra-Reynoso L; Lazo-de-la-Vega-Monroy ML; Alonso-Castro AJ; Sánchez-Barajas M; Alvarez-Alvarez RM; Del Carmen Preciado-Puga M Curr HIV Res; 2020; 18(5):308-314. PubMed ID: 32684151 [TBL] [Abstract][Full Text] [Related]
6. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients. Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887 [TBL] [Abstract][Full Text] [Related]
7. Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading. Korwutthikulrangsri M; Mahachoklertwattana P; Chanprasertyothin S; Pongratanakul S; Poomthavorn P Clin Endocrinol (Oxf); 2015 Dec; 83(6):820-7. PubMed ID: 25929297 [TBL] [Abstract][Full Text] [Related]
8. Relationship between neck circumference, insulin resistance and arterial stiffness in overweight and obese subjects. Fantin F; Comellato G; Rossi AP; Grison E; Zoico E; Mazzali G; Zamboni M Eur J Prev Cardiol; 2017 Sep; 24(14):1532-1540. PubMed ID: 28728486 [TBL] [Abstract][Full Text] [Related]
9. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262 [TBL] [Abstract][Full Text] [Related]
10. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. Singh Y; Garg MK; Tandon N; Marwaha RK J Clin Res Pediatr Endocrinol; 2013; 5(4):245-51. PubMed ID: 24379034 [TBL] [Abstract][Full Text] [Related]
11. Low serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey. Tosunbayraktar G; Bas M; Kut A; Buyukkaragoz AH Afr Health Sci; 2015 Dec; 15(4):1161-9. PubMed ID: 26958017 [TBL] [Abstract][Full Text] [Related]
12. The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men. Sargeant JA; Aithal GP; Takamura T; Misu H; Takayama H; Douglas JA; Turner MC; Stensel DJ; Nimmo MA; Webb DR; Yates T; King JA Appl Physiol Nutr Metab; 2018 May; 43(5):482-490. PubMed ID: 29220580 [TBL] [Abstract][Full Text] [Related]
13. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761 [TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Tan BK; Hallschmid M; Adya R; Kern W; Lehnert H; Randeva HS Diabetes; 2011 Nov; 60(11):2758-62. PubMed ID: 21926274 [TBL] [Abstract][Full Text] [Related]
15. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome. Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238 [TBL] [Abstract][Full Text] [Related]
16. A review of fibroblast growth factor 21 in diabetic cardiomyopathy. Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491 [TBL] [Abstract][Full Text] [Related]
17. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes. Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902 [TBL] [Abstract][Full Text] [Related]
18. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status. Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360 [TBL] [Abstract][Full Text] [Related]
19. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452 [TBL] [Abstract][Full Text] [Related]
20. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans. Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]